Serotonin-norepinephrine reuptake inhibitors
GPTKB entity
Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
class of antidepressant drugs
|
| gptkbp:abbreviation |
gptkb:SNRIs
|
| gptkbp:approvedBy |
1993
|
| gptkbp:contraindication |
uncontrolled hypertension
|
| gptkbp:drugClass |
antidepressant
|
| gptkbp:example |
gptkb:venlafaxine
gptkb:desvenlafaxine gptkb:levomilnacipran gptkb:milnacipran gptkb:duloxetine |
| gptkbp:firstSNRI |
gptkb:venlafaxine
|
| https://www.w3.org/2000/01/rdf-schema#label |
Serotonin-norepinephrine reuptake inhibitors
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
inhibit reuptake of serotonin and norepinephrine
|
| gptkbp:pregnancyCategory |
varies by drug
|
| gptkbp:relatedTo |
gptkb:tricyclic_antidepressants
gptkb:selective_serotonin_reuptake_inhibitors |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
insomnia dry mouth sexual dysfunction increased blood pressure |
| gptkbp:usedFor |
gptkb:major_depressive_disorder
chronic pain anxiety disorders |
| gptkbp:bfsParent |
gptkb:Antidepressants
|
| gptkbp:bfsLayer |
6
|